Oxycodone Orifarm (Oxycodone Hydrochloride)

Oxycodone Orifarm is an opioid that acts on the central nervous system to relieve pain associated with several conditions.

• Cancer‑related pain: Provides sustained relief of moderate to severe malignant pain.
• Post‑surgical pain: Controls acute pain following major surgical procedures.
• Chronic non‑cancer pain: Alleviates persistent pain when other treatments have failed.
• Traumatic injury pain: Reduces pain from severe musculoskeletal injuries.
• Palliative care pain: Improves comfort in end‑of‑life care.

• Oxycodone binds to μ‑opioid receptors in the brain and spinal cord, activating inhibitory G‑protein pathways that decrease neuronal excitability and reduce the transmission of nociceptive signals. This results in an elevated pain threshold and diminished perception of pain.

Oxycodone Orifarm may cause a range of adverse reactions, from mild to potentially life‑threatening.

Common Side Effects

• Constipation: Reduced gastrointestinal motility leading to hard stools.
• Nausea: Feeling of queasiness, sometimes with vomiting.
• Drowsiness: Generalized sedation or fatigue.
• Dizziness: Light‑headed sensation, especially when standing quickly.
• Dry mouth: Reduced salivation causing oral discomfort.
• Pruritus: Itchy skin without rash.

Serious or Rare Side Effects

• Respiratory depression: Markedly slowed breathing that can be fatal.
• Severe hypotension: Dangerous drop in blood pressure.
• Seizures: Uncontrolled convulsive episodes.
• Allergic reactions: Rash, swelling, or anaphylaxis.
• Dependence and withdrawal: Physical and psychological reliance with withdrawal symptoms on abrupt cessation.
• Cardiac arrhythmias: Irregular heart rhythms that may require emergency care.

When prescribing Oxycodone Orifarm, clinicians should evaluate patient history and monitor for adverse outcomes.

• Assess renal and hepatic function: Adjust dosing in patients with impairment.
• Evaluate risk of addiction: Screen for substance‑use disorder before initiating therapy.
• Avoid concurrent CNS depressants: Concomitant use with alcohol or benzodiazepines can increase sedation.
• Monitor for respiratory depression: Observe breathing, especially after dose escalation.
• Counsel on constipation management: Recommend dietary fiber, fluids, and laxatives as needed.
• Store below 25°C: Keep in the original container, protect from moisture and direct sunlight.

Oxycodone Orifarm can interact with several medication classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Benzodiazepines: Combined use markedly increases risk of respiratory depression and profound sedation.
• CNS depressants: Other sedatives, including barbiturates and antihistamines, can potentiate central nervous system depression.
• MAO‑inhibitors: May cause hypertensive crisis or serotonin syndrome when combined.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): Increase oxy‑hydro‑hydro­hyd    ");